Skip to main content

Table 4 Postoperative outcome

From: Combining aortic arch dissection stent implantation and root surgery for aortic dissection type A

 

AMDS

Control

P-value

(n = 9)

(n = 111)

Hospital stay, d (mean ± SD)

20.4 ± 19.9

17.0 ± 13.3

0.87

ICU stay, h (mean ± SD)

140 ± 190

186 ± 272

0.51

Mechanical ventilation, h (mean ± SD)

23.3 ± 17.9

50.3 ± 54.0

0.27

Tracheostomy, n (%)

1 (11.1)

9/106 (8.5)

0.57

Chest tube drainage volume, ml (mean ± SD)

901 ± 617

1392 ± 1144

0.13

Blood transfusions

 Packed red blood cells, n (mean ± SD)

1.78 ± 2.11

2.72 ± 4.43

0.87

 Packed platelets, n (mean ± SD)

0.67 ± 0.87

0.90 ± 2.04

0.52

 Packed fresh frozen plasma, n (mean ± SD)

3.56 ± 4.13

3.50 ± 4.57

0.86

Left ventricular ejection fraction, % (mean ± SD)

45.8 ± 22.7

46.8 ± 24.5

0.34

In-hospital adverse events

 MACCE, n (%)

4 (44.4)

43/111 (38.7)

0.74

 In-hospital death, n (%)

1 (11.1)

24/110 (21.8)

0.68

  Death within 24 h after surgery, n (%)

0 (0.0)

10/110 (9.1)

> 0.99

 Extracorporeal life support, n (%)

1 (11.1)

13/106 (12.3)

> 0.99

 Cardiopulmonary resuscitation, n (%)

2 (22.2)

10/105 (9.5)

0.24

 Reoperation, n (%)

3 (33.3)

28/108 (25.9)

0.70

  Thoracic bleeding, n (%)

2 (66.7)

23 (82.1)

 

  Pacemaker implantation, n (%)

0 (0.0)

1 (3.6)

 

  Wound healing disorder, n (%)

0 (0.0)

1 (3.6)

 

  Other, n (%)

1 (33.3)

3 (10.7)

 

 Vascular intervention, n (%)

1 (11.1)

13/106 (12.3)

> 0.99

 Multi organ dysfunction syndrome, n (%)

1 (11.1)

6/106 (5.7)

0.44

 Stroke, n (%)

2 (22.2)

18/106 (17.0)

0.65

 Thromboembolism, n (%)

1 (11.1)

4/106 (3.8)

0.34

 Hemodialysis, n (%)

1 (11.1)

24/107 (22.4)

0.68

 Sepsis, n (%)

0 (0.0)

1/106 (0.9)

> 0.99

 Compartment syndrome, n (%)

0 (0.0)

4/105 (3.8)

> 0.99

 Hematothorax, n (%)

2 (22.2)

18/108 (16.7)

0.65

 Arrhythmia, n (%)

5 (55.6)

48/108 (44.4)

0.73

 Respiratory failure, n (%)

2 (22.2)

20/107 (18.7)

0.68

Postoperative laboratory values

 First postoperative day

  Troponin T, ng/l (mean ± SD)

11,649 ± 30,155

3,328 ± 6,378

0.95

  Creatine kinase, U/l (mean ± SD)

3,351 ± 3,761

5,385 ± 16,518

0.39

  Creatinine, mg/dl (mean ± SD)

1.48 ± 0.41

1.68 ± 0.74

0.80

  Urea, mg/dl (mean ± SD)

45.6 ± 11.9

65.5 ± 30.4

0.03

  Hemoglobin, g/dl (mean ± SD)

9.43 ± 1.80

9.53 ± 1.71

0.50

  Aspartate amino transferase, U/l (mean ± SD)

283 ± 259

348 ± 581

0.44

  Alanine amino transferase, U/l (mean ± SD)

123 ± 96

141 ± 245

0.30

  Platelets, 103/µl (mean ± SD)

130 ± 35

140 ± 75

0.97

 Fifth postoperative day

  Troponin T, ng/l (mean ± SD)

522 ± 239

1,459 ± 1,989

0.23

  Creatine kinase, U/l (mean ± SD)

924 ± 930

1,689 ± 6,023

0.38

  Creatinine, mg/dl (mean ± SD)

1.27 ± 0.57

1.40 ± 0.79

0.86

  Urea, mg/dl (mean ± SD)

84.6 ± 37.2

69.3 ± 33.2

0.24

  Hemoglobin, g/dl (mean ± SD)

9.24 ± 0.47

10.06 ± 1.46

0.08

  Aspartate amino transferase, U/l (mean ± SD)

647 ± 1,330

137 ± 285

0.72

  Alanine amino transferase, U/l (mean ± SD)

788 ± 869

98 ± 107

< 0.01

  Platelets, 103/µl (mean ± SD)

131 ± 44

138 ± 75

0.97

  1. Postoperative in-hospital outcome after surgery for acute type A aortic dissection. Patients with additional implantation of a novel non-covered hybrid prosthesis (AMDS, ARTIVION, Kennesaw, USA) (AMDS, n = 9) were compared to controls (n = 111)
  2. ICU intensive care unit, MACCE major adverse cardiovascular and cerebrovascular event